Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00267488
Status:
COMPLETED
Last Update Posted:
2012-07-11
First Post:
2005-12-20
Brief Title:
Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer
Sponsor:
Organization:
GlaxoSmithKline